Atherosclerosis manifests itself clinically at advanced stages when plaques undergo
hemorrhage and/or rupture with superimposed thrombosis, thus abruptly stopping blood …

Myocardial infarction (MI), a leading cause of death around the world, displays a complex
pattern of inheritance,. When MI occurs early in life, genetic inheritance is a major …

Apolipoprotein A5 (ApoA5) is a key regulator of plasma triglycerides (TG), even though its
plasma concentration is very low compared to other known apoproteins. Over the years …

BACKGROUND Increased nonfasting plasma triglycerides marking increased amounts of
cholesterol in remnant lipoproteins are important risk factors for cardiovascular disease, but …

Pharmacovigilance involves continually monitoring drug safety after drugs are put to market.
To aid this process; algorithms for the identification of strongly correlated drug/adverse drug …

Gestational diabetes mellitus (GDM) is the most frequent metabolic disorder in pregnancy.
Women with a GDM history are at increased risk of developing diabetes and cardiovascular …

Abstract Apolipoprotein C3 (apoC3) and apolipoprotein A5 (apoA5), encoded by
APOA1/C3/A4/A5 gene cluster, are two critical regulators of plasma triglyceride (TG) …

Aim Gestational diabetes mellitus (GDM) is the most frequent metabolic disorder in
pregnancy and it can be considered a silent risk associated to T2DM and CVD later in life …

New and known genetic determinants of plasma levels of LDL cholesterol, lipoprotein (a),
and triglyceride-rich lipoproteins are concordant with both the magnitude and direction of the …

Acute myocardial infarction remains a significant cause of mortality worldwide and its burden
continues to grow. Its pathophysiology is known to be complex and multifactorial, with …